Impact of Adalimumab Therapy on Brachial Endothelial Function and Large Artery Stiffness in Patients With Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 23 Jul 2015
Price : $35 *
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 21 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Nov 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Oct 2013 New trial record